Skip to content
  • THE PROJECT
  • NEWS & PRESS
  • PUBLICATIONS
  • MEMBER-AREA
  • THE PROJECT
  • NEWS & PRESS
  • PUBLICATIONS
  • MEMBER-AREA

News & Press

02.08.2022

priMe update: QFT Workshop in Nairobi

Read More
11.07.2022

priMe annual meeting: Milestone “End of recruitment” reached!

Read More
22.06.2022

Milestone achieved: end of recruitment completed

Read More
03.05.2022

priMe update: visit to the East African clinical sites

Read More
23.03.2022

March 24 is the World Tuberculosis (TB) day!

Read More
27.10.2021

Visit of the South African clinical sites

Read More
26.10.2021

Milestone achieved

Read More
07.09.2021

Update on priMe

Read More
04.06.2021

Recruitment has started at all clinical centers

Read More
08.04.2021

priMe in the South African press

Read More
17.03.2021

Milestone achieved: Initiation of all clinical centers for priMe trial completed

Read More
25.01.2021

Update on priMe clinical trial

Read More
03.12.2020

First clinical center in South Africa initiated for priMe trial

Read More
11.11.2020

First vaccinee enrolled in the priMe trial

Read More
27.08.2020

VPM receives 30 Million Euro Loan from the EIB for TB

Read More
26.02.2020

priMe AVAREF Meeting

Read More
02.12.2019

priMe Investigator Meeting

Read More
15.02.2019

priMe Kick-off Meeting

Read More
  • THE PROJECT
  • NEWS & PRESS
  • PUBLICATIONS
  • MEMBER-AREA
  • Contact
  • Imprint
  • Privacy policy
  • THE PROJECT
  • NEWS & PRESS
  • PUBLICATIONS
  • MEMBER-AREA

Vakzine Projekt Management GmbH

Ahrensburger Strasse 1
30659 Hannover
Germany

Phone: +49 511 16 99 08 0
Fax: +49 511 16 99 08 29
E-Mail: info@prime-vaccine.eu

This project is part of the EDCTP2 programme
supported by the European Union

Print
Top
  • Contact
  • Imprint
  • Privacy-policy

© 2022 Vakzine Projekt Management GmbH. All Rights Reserved.